LOG IN
SIGN UP
KESScientific program
Luncheon symposium
- Luncheon symposium 1. [CKD-Pharm & Boehringer Ingelheim] Day 2, Friday, May 2, 12:10-12:40 / Room 1 (B2)
Chairpersons : Gwang Won Kim (Gachon University, Korea), Ho-Young Son (The Catholic University of Korea, Korea)
|
12:10-12:25 | Strategies for blood glucose management in elderly diabetes patients in an aging society Ji A Seo (Korea University, Korea) |
|
12:25-12:40 | Esgliteo, optimal clinical approach to combination use of SGLT2i and DPP-4i Gyuri Kim (Sungkyunkwan University, Korea) |
- Luncheon symposium 2. [LG Chem & Daewoong] Day 2, Friday, May 2, 12:10-12:40 / Room 2 (B2)
Chairpersons : Hong Kyu Lee (Seoul National University, Korea), Hyun Koo Yoon (CHEIL-CLINIC, Korea)
|
12:10-12:25 | Optimal diabetes management with evidence-based 'ZEMIDAPA' Hae Kyung Kim (Yonsei University, Korea) |
|
12:25-12:40 | Continuous glucose monitoring for all individuals with type 2 diabetes: is that a realistic goal? Ramzi Ajjan (University of Leeds, UK) |
- Luncheon symposium 3. [Novo Nordisk & Dong-A ST] Day 2, Friday, May 2, 12:10-12:40 / Room 3 (1F)
Chairpersons : Seong-Yeon Kim (Seoul National University, Korea), Hyoung Woo Lee (Yeungnam University, Korea)
|
12:10-12:25 | Proven superior efficacy of basal insulin combinations in T2D management: the impact of IDegLira Eun Young Lee (The Catholic University of Korea, Korea) |
|
12:25-12:40 | When and how to start initial combination therapy in T2D Yun Kyung Jeon (Pusan National University, Korea) |
- Luncheon symposium 4. [Yuhan & Hanmi-Pharm] Day 3, Saturday, May 3, 12:50-13:20 / Room 1 (B2)
Chairpersons: Ie Byung Park (Gachon University, Korea), Suk Kyeong Kim (Konkuk University, Korea)
|
12:50-13:05 | Empagliflozin: leading a new era in Cardiovascular-Kidney-Metabolic syndrome Kyung-Soo Kim (CHA University, Korea) |
|
13:05-13:20 | Introducing denosumab and the SB16 Biosimilar: it’s potential role for the management of osteoporosis Kyoung Jin Kim (Korea University, Korea) |
- Luncheon symposium 5. [Sanofi & AstraZeneca] Day 3, Saturday, May 3, 12:50-13:20 / Room 2 (B2)
Chairpersons : Kyungwan Min (Eulji University, Korea), Yang Ho Kang (Pusan National University, Korea)
|
12:50-13:05 | Enhancing glucose control by simplified and optimized combination with insulin-based therapy Jang Won Son (The Catholic University of Korea, Korea) |
|
13:05-13:20 | The benefits of combination therapies, including the brand-name dapagliflozin Jae Hyun Bae (Seoul National University, Korea) |
- Luncheon symposium 6. [Handok & JW-Pharm] Day 3, Saturday, May 3, 12:50-13:20 / Room 3 (1F)
Chairpersons : Seungjoon Oh (Kyunghee University, Korea), Heung Yong Jin (Jeonbuk National University, Korea)
|
12:50-13:05 | Improving blood glucose control in hospitals: clinical applications of BarozenFit Joonyub Lee (The Catholic University of Korea, Korea) |
|
13:05-13:20 | Cutting edge care of pitavastatin with ezetimibe combination therapy Hwi Seung Kim (Chung-Ang University, Korea) |